Evidence map›Paper›PMID 29103101›Full record

ArticleTranslational stroke research2018

Ischemic Preconditioning Protects Astrocytes against Oxygen Glucose Deprivation Via the Nuclear Erythroid 2-Related Factor 2 Pathway.

Srinivasan V Narayanan, Kunjan R Dave, Miguel A Perez-Pinzon

Open access · greenAbstract read
In one paragraph

Article in Translational stroke research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Long non-coding RNA SNHG12 regulates leptomeningeal collateral remodeling via RGMa after ischemic stroke.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Improved post-stroke spontaneous recovery by astrocytic extracellular vesicles.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Srinivasan V NarayananCerebral Vascular Disease Research Laboratories, School of Medicine, University of Miami Miller, Miami, FL, USA.
Kunjan R DaveCerebral Vascular Disease Research Laboratories, School of Medicine, University of Miami Miller, Miami, FL, USA.
Miguel A Perez-PinzonCerebral Vascular Disease Research Laboratories, School of Medicine, University of Miami Miller, Miami, FL, USA. perezpinzon@miami.edu.
University of Miami · US

Funding

ISCHEMIC PRECONDITIONING: MECHANISMS OF NEUROPROTECTIONR01NS034773 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MIGUEL A PEREZ-PINZON · 2003 to 2026
$6.7M
MECHANISMS OF NEUROPROTECTION AGAINST CARDIAC ARRESTR01NS045676 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEREZ-PINZON, MIGUEL A · 2004 to 2024
$5.1M
Metabolic Master Regulators for Ischemic NeuroprotectionR01NS097658 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEREZ-PINZON, MIGUEL A · 2017 to 2021
$2.1M
ISCHEMIC PRECONDITIONING: MECHANISMS OF NEUROPROTECTIONRF1NS034773 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEREZ-PINZON, MIGUEL A · 2022 to 2022
$1.7M
Mitochondria and Cerebral ischemia: intracellular signalingR01NS054147 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEREZ-PINZON, MIGUEL A · 2006 to 2009
$1.3M
ISCHEMIC PRECONDITIONING--MECHANISMS OF NEUROPROTECTIONR29NS034773 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEREZ-PINZON, MIGUEL A · 1997 to 2001
$267k
Role of Nrf2 in Ischemic Preconditioning-Induced NeuroprotectionF31NS080344 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI NARAYANAN, SRINIVASAN V · 2012 to 2014
$135k
ISCHEMIC PRECONDITIONING--ROLE OF ADENOSINER55NS034773 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PEREZ-PINZON, MIGUEL A · 1996 to 1996
–
NINDS NIH HHS F31 NS080344NINDS NIH HHS F31 NS080344.NINDS NIH HHS NS054147NINDS NIH HHS NS34773NINDS NIH HHS NS45676NINDS NIH HHS R01 NS034773NINDS NIH HHS R01 NS045676NINDS NIH HHS R01 NS054147NINDS NIH HHS R01 NS097658NINDS NIH HHS R29 NS034773NINDS NIH HHS RF1 NS034773
6 · The paper itself

Abstract

Induction of ischemic preconditioning (IPC) represents a potential therapy against cerebral ischemia by activation of adaptive pathways and modulation of mitochondria to induce ischemic tolerance to various cells and tissues. Mitochondrial dysfunction has been ascribed to contribute to numerous neurodegenerative conditions and cerebral ischemia. Nuclear erythroid 2-related factor 2 (Nrf2) is a transcription factor that has traditionally been involved in upregulating cellular antioxidant systems to combat oxidative stress in the brain; however, the association of Nrf2 with mitochondria in the brain remains unclear. In the present study, we investigated the effects of Nrf2 on (i) IPC-induced protection of astrocytes; (ii) OXPHOS protein expression; and (iii) mitochondrial supercomplex formation.Oxygen-glucose deprivation (OGD) was used as an in vitro model of cerebral ischemia and IPC in cultured rodent astrocytes derived from WT C57Bl/6J and Nrf2

Indexed as

Analysis of VarianceAnimalsAnimals, NewbornAstrocytesCells, CulturedElectron-Transferring FlavoproteinsGlucoseHypoxiaIschemic PreconditioningL-Lactate DehydrogenaseMice, TransgenicMitochondriaNeuroprotective AgentsNF-E2-Related Factor 2OxygenRatsElectron-Transferring FlavoproteinsGlucoseL-Lactate DehydrogenaseNeuroprotective AgentsNF-E2-Related Factor 2OxygenMitochondriaNrf2PreconditioningReactive oxygen species

Identifiers

PMID29103101
PMCPMC6771255
OpenAlexW2765567910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.